KMID : 1044520210840030200
|
|
Tuberculosis and Respiratory Diseases 2021 Volume.84 No. 3 p.200 ~ p.208
|
|
Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
|
|
Mostafa Amira Ismail
Salem Ayman Elsayed Ahmed Heba Allah Moussa Bayoumi Aml Ibrahim Halim Radwa M. Abdel Samie Rasha M. Abdel
|
|
Abstract
|
|
|
Background: Hypersensitivity pneumonitis (HP) is an increasingly recognized form of diffuse parenchymal lung disease. Krebs von den Lungen-6 (KL-6) is now classified as a human MUC1 mucin protein, and regenerating type II pneumocytes are the primary cellular source of KL-6/MUC1 in the affected lungs of patients with interstitial lung diseases (ILD). Serum KL-6/MUC1 levels have been demonstrated to be useful for the evaluation of various ILD. To determine the role of circulating KL-6 in evaluating the disease activity and management of HP.
Methods: An observational cross-sectional study was conducted on 51 patients with HP and 20 healthy controls. Serum KL-6 levels were measured in both groups. Patients were further assessed based on chest high-resolution computed tomography (HRCT), pulmonary function test, 6-minute walk test, echocardiography, bronchioalveolar lavage, and/or transbronchial biopsy. Patients were divided into the fibrotic and non-fibrotic groups according to the HRCT findings.
Results: The median serum KL-6 levels were significantly higher in HP patients as compared to the control group. The median serum KL-6 levels were found to be higher in the non-fibrotic HP group (1,900 IU/mL) as compared to the fibrotic group (1,200 IU/mL). There was a significant inverse correlation between serum KL-6 serum level and the dose of steroids as well as the duration of steroid therapy.
Conclusion: The presence of higher KL-6 levels in the non-fibrotic HP group implies its enhanced production by regenerating pneumocytes in response to alveolar injury. The significant association between serum KL-6 levels and the dose and the duration of steroid therapy emphasizes the significant role of steroids in the stabilization of the disease.
|
|
KEYWORD
|
|
Hypersensitivity Pneumonitis, Serum Biomarker, KL-6, Assessment of Severity
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|